TrialRadiology and oncology2020

Influence of concurrent capecitabine based chemoradiotherapy with bevacizumab on the survival rate, late toxicity and health-related quality of life in locally advanced rectal cancer: a prospective phase II CRAB trial.

Vaneja Velenik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.